Literature DB >> 26224372

Preoperative Slow-Release Morphine Reduces Need of Postoperative Analgesics and Shortens Hospital Stay in Laparoscopic Gastric Bypass.

Jakob Hedberg1, Hanna Zacharias1, Lars Janson2, Magnus Sundbom3.   

Abstract

BACKGROUND: As most bariatric procedures are performed by laparoscopy, hospital stay is exceptionally short, despite the habitus of patients and the rather extensive intra-abdominal surgery. To facilitate postoperative mobilization, most patients are given repeated single doses of morphine, a drug with several side effects. We aimed to evaluate the effect of preoperative treatment with a tablet of slow-release morphine (SRM) on postoperative analgesic consumption and length of stay (LOS) in laparoscopic gastric bypass (LGBP).
METHODS: The SRM group (244 patients) was retrospectively compared to a control group (197 patients) concerning postoperative pain management and hospital stay by studying medical charts and data from Scandinavian Obesity Surgery Registry (SOReg).
RESULTS: Patients in the SRM group needed significantly less analgesics during days 0, 1, and 2 postoperatively, morphine 10.7 vs. 13.6 mg, 10.2 vs. 13.9 mg, and 1.1 vs. 3.6 mg, respectively, p < 0.05, as well as acetaminophen, p < 0.05. According to a subgroup analysis, 20 mg of SRM was needed to obtain these effects. In addition, SRM patients had shorter hospital stay (2.3 vs. 3.5 days, p < 0.05) than the control group. No negative side effects were seen.
CONCLUSIONS: Preoperatively administered slow-release morphine significantly reduced the need for postoperative analgesics and shortened hospital stay, without side effects or other complications. At our department, the studied regime is now routinely used in all bariatric surgery and we have started to use the concept in other groups of surgical patients.

Entities:  

Keywords:  Analgesics; Laparoscopic gastric bypass; Morphine; Postoperative care; Prolonged-release morphine

Mesh:

Substances:

Year:  2016        PMID: 26224372     DOI: 10.1007/s11695-015-1817-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

Review 1.  Analgesic treatment in laparoscopic gastric bypass surgery: a systematic review of randomized trials.

Authors:  Lars P H Andersen; Mads U Werner; Jacob Rosenberg; Ismail Gögenur
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

2.  Opioid requirements after laparoscopic bariatric surgery.

Authors:  Toby N Weingarten; Juraj Sprung; Antolin Flores; Ana M Oviedo Baena; Darrell R Schroeder; David O Warner
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

3.  Predictors of hospital stay following laparoscopic gastric bypass: analysis of 9,593 patients from the National Surgical Quality Improvement Program.

Authors:  Jonathan Carter; Steven Elliott; Jennifer Kaplan; Matthew Lin; Andrew Posselt; Stanley Rogers
Journal:  Surg Obes Relat Dis       Date:  2014-05-23       Impact factor: 4.734

4.  Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass.

Authors:  Shireesh Saurabh; Jessica K Smith; Mark Pedersen; Paul Jose; Peter Nau; Isaac Samuel
Journal:  Surg Obes Relat Dis       Date:  2014-09-30       Impact factor: 4.734

5.  Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome.

Authors:  Torsten Olbers; Hans Lönroth; Monika Fagevik-Olsén; Lars Lundell
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

Review 6.  Challenges in the optimisation of post-operative pain management with opioids in obese patients: a literature review.

Authors:  C Lloret-Linares; A Lopes; X Declèves; A Serrie; S Mouly; J-F Bergmann; S Perrot
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

7.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

8.  Postoperative Opioid Requirements Following Roux-en-Y Gastric Bypass in Patients Receiving Continuous Bupivacaine Through a Pump System: A Retrospective Review.

Authors:  Andrew R Cohen; April N Smith; Brian S Henriksen
Journal:  Hosp Pharm       Date:  2013-06

9.  Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity.

Authors:  M Sundbom; S Gustavsson
Journal:  Br J Surg       Date:  2004-04       Impact factor: 6.939

10.  Assessing the feasibility of a randomised, double-blinded, placebo-controlled trial to investigate the role of intraperitoneal ropivacaine in gastric bypass surgery: a protocol.

Authors:  Robert Wu; Fatima Haggar; N'Gai Porte; Naveen Eipe; Isabelle Raiche; Amy Neville; Jean Denis Yelle; Tim Ramsay; Joseph Mamazza
Journal:  BMJ Open       Date:  2014-08-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.